Discussion on a recent study by Novo Nordisk on weight loss drug WeGoV, its impact on cardiovascular disease, and positive developments in the field of weight loss drugs.
Bloomberg Opinion Pharma Columnist Lisa Jarvis and Bloomberg News Health Reporter Madison Muller discuss a how a clinical trial in obesity drugs is punctuating a string of positive developments that could make the treatments more widely accessible. Kate Hao, Founder and CEO of Happy Mango, talks about helping immigrants secure loans for cars, homes and businesses. Bloomberg Businessweek Editor Joel Weber and Bloomberg News Senior Economics Writer Shawn Donnan provide the details of Shawn's Businessweek story Biden and Xi Meet at APEC to Navigate Rivalry and Economic Ties. And we Drive to the Close with David Dietze, Senior Portfolio Strategist at Peapack Private Wealth Management.
Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.
See omnystudio.com/listener for privacy information.